[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.157.19.94. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Correspondence
June 2001

Use of the 308-nm Excimer Laser for Postresurfacing Leukoderma

Arch Dermatol. 2001;137(6):824-825. doi:

Leukoderma is a common, late complication of carbon dioxide laser resurfacing1 and is usually very distressing to patients. Grimes et al2 recently reported a pilot study in which topical psoralen plus UV-A therapy induced moderate to excellent repigmentation in 71% of patients with postresurfacing hypopigmentation. Immunohistochemical staining with Fontana-Masson and Mel-5 revealed evidence of residual melanocytes and epidermal melanin.2

First Page Preview View Large
First page PDF preview
First page PDF preview
×